DPC Writes to Oklahoma Legislators to Request a "No" Vote on 340B Expansion

Domestic Policy Caucus Secretary/Treasurer Kent Kaiser, Ph.D., today wrote to members of the Oklahoma House of Representatives Civil Judiciary Committee to request a "no" vote on House Bill 2048, which would expand the 340B drug pricing program in the state.

In part, DPC wrote, "Before it is ever expanded, the 340B program needs to be reformed. You should pursue reforms that include oversight and transparency so that hospitals and pharmacies must report exactly how much revenue they generate from the 340B program and exactly how much of that money is used to provide prescription drug discounts to patients like the original law intended. You should also define exactly who is a 340B patient, and you should require that patients be notified if they are designated as 340B patients. This would be a good start before ever thinking about expanding the 340B program in Oklahoma... Please vote “no” on expanding 340B. Oppose HB2048."

Read the full letter here.